Joint Filer Information
Name: | Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and Deerfield Partners, L.P. |
Address: | 780 Third Avenue, 37th Floor New York, NY 10017 |
Designated Filer: | James E. Flynn |
Issuer and Ticker Symbol: | Black Diamond Therapeutics, Inc. [BDTX] |
Date of Event Requiring Statement: | January 29, 2020 |
The undersigned, Deerfield Mgmt, L.P., Deerfield Management Company, L.P. and Deerfield Partners, L.P., are jointly filing the attached Initial Statement of Beneficial Ownership on Form 3 with James E. Flynn with respect to the beneficial ownership of securities of Black Diamond Therapeutics, Inc.
Signatures:
DEERFIELD MGMT, L.P.
By: J.E. Flynn Capital, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
| |
DEERFIELD MANAGEMENT COMPANY, L.P.
By: Flynn Management LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
| |
DEERFIELD PARTNERS, L.P.
By: Deerfield Mgmt, L.P., General Partner
By: J.E. Flynn Capital, LLC, General Partner
By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact |